Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
Optum is a division of UnitedHealth Group ... FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.